Literature DB >> 2018831

Point mutations in the L-type pyruvate kinase gene of two children with hemolytic anemia caused by pyruvate kinase deficiency.

B Neubauer1, M Lakomek, H Winkler, M Parke, S Hofferbert, W Schröter.   

Abstract

The molecular alterations responsible for the characteristic enzyme abnormalities in pyruvate kinase (PK) deficiency were investigated in two unrelated children homozygous for PK deficiency. Both variant enzymes were characterized according to the recommendations of the International Committee for Standardization in Haematology. Genomic DNA was specifically amplified by the polymerase chain reaction. Normal and mutant alleles of the L-type PK gene were analyzed by nucleotide sequencing. Heterozygosity of the parents was confirmed by allele-specific oligonucleotide hybridization. In PK Linz a C to T base exchange at position 394 of the L-type PK gene was found. As a result, the 132nd amino acid of the mutant enzyme, arginine (CGC), is replaced by cysteine (TGC). The affected amino acid residue is located within the deduced active site of the protein and the enzyme variant shows strongly altered allosteric properties. PK Beirut shows a C for T substitution at position 1058, changing the 353 amino acid from threonine (ACG) to methionine (ATG). In contrast to PK Linz, this amino acid lies outside the deduced substrate binding site and kinetic parameters of PK Beirut are close to normal. Both enzyme variants show a markedly reduced specific activity and thermolability.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2018831

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Path to facilitate the prediction of functional amino acid substitutions in red blood cell disorders--a computational approach.

Authors:  Rajith B; George Priya Doss C
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

2.  Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia.

Authors:  L Baronciani; E Beutler
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

3.  Tight linkage of pyruvate kinase (PKLR) and glucocerebrosidase (GBA) genes.

Authors:  D Glenn; T Gelbart; E Beutler
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

4.  Analysis of pyruvate kinase-deficiency mutations that produce nonspherocytic hemolytic anemia.

Authors:  L Baronciani; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  Mutations in the R-type pyruvate kinase gene and altered enzyme kinetic properties in patients with hemolytic anemia due to pyruvate kinase deficiency.

Authors:  M Lakomek; P Huppke; B Neubauer; A Pekrun; H Winkler; W Schröter
Journal:  Ann Hematol       Date:  1994-11       Impact factor: 3.673

Review 6.  Modulation of allostery of pyruvate kinase by shifting of an ensemble of microstates.

Authors:  J Ching Lee
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-07       Impact factor: 3.848

7.  Fetal anaemia due to pyruvate kinase deficiency.

Authors:  F Gilsanz; M A Vega; E Gómez-Castillo; J A Ruiz-Balda; F Omeñaca
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

8.  Assessment of coding region variants in Kuwaiti population: implications for medical genetics and population genomics.

Authors:  Sumi Elsa John; Dinu Antony; Muthukrishnan Eaaswarkhanth; Prashantha Hebbar; Arshad Mohamed Channanath; Daisy Thomas; Sriraman Devarajan; Jaakko Tuomilehto; Fahd Al-Mulla; Osama Alsmadi; Thangavel Alphonse Thanaraj
Journal:  Sci Rep       Date:  2018-11-08       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.